Kentucky biotech Apellis plans major expansion in Mass.

The company's drug would be the first-ever treatment for geographic atrophy, a leading cause of blindness that affects 1 million Americans annually.

Source: bizjournals.com Health Care:Biotechnology headlines - August 23, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news